
WuXi Biologics Investor Relations Material
Latest events

H1 2025
WuXi Biologics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from WuXi Biologics (Cayman) Inc
Access all reports
WuXi Biologics (Cayman) Inc. is a global contract research, development, and manufacturing organization (CRDMO) focused on biologics. The company offers comprehensive services that span from biologic discovery and development to commercial manufacturing. Key offerings include protein generation, antibody development, assay development, and regulatory affairs. The company is headquartered in Wuxi, China, and its shares are listed on the Hong Kong Stock Exchange.
Key slides for WuXi Biologics (Cayman) Inc


Our CRDMO Business Model Explained Presentation
WuXi Biologics (Cayman) Inc


H1 2025
WuXi Biologics (Cayman) Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
2269
Country
🇭🇰 Hong Kong